Literature DB >> 15340259

HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.

Jeremy R Jass1.   

Abstract

Morphological features may serve as diagnostically useful markers of colorectal cancer (CRC) with the microsatellite instability-high (MSI-H) phenotype. The most important of these are lymphocytic infiltration, mucin secretion and poor differentiation. These features are apparent in both sporadic MSI-H CRC and CRC occurring in the context of hereditary non-polyposis colorectal cancer (HNPCC). There is now strong evidence that that the two principal subtypes of MSI-H CRC evolve through different pathways. Sporadic MSI-H CRC orginate within serrated polyps with BRAF mutation and DNA methylation while CRC in HNPCC arise within conventional adenomas in which there is frequent mutation of APC or beta -catenin and/or K- ras. These early differences in pathogenesis translate into multiple morphological distinctions in the cancers developing through the two pathways. Lymphocytic infiltration, tumour budding (de-differentiation), and co-existing adenomas are more evident in HNPCC while mucin secretion, poor differentiation, tumour heterogeneity and glandular serration, and co-existing serrated polyps are more evident in sporadic MSI-H CRC. Sporadic MSI-H CRC are also characterized by cytoplasmic eosinophilia and nuclei that are large, round, vesicular and contain a prominent nucleolus while in HNPCC the cytological features recapitulate the basophilia and nuclear characteristics of conventional adenomas. In practice, lymphocytic infiltration is the most sensitive marker of MSI-H status in both sporadic CRC and HNPCC. The crucial distinction between HNPCC and sporadic MSI-H CRC should be achieved by means of all available data including family history, age at onset of malignancy and molecular features. There is increasing evidence that genetic factors may predispose to DNA methylation. This can result in familial clustering of MSI-H CRC in which the underlying mechanism is methylation of hMLH1 rather than germline mutation. Morphological features can assist is distinguishing such families from bona fide HNPCC families which they closely mimic.

Entities:  

Mesh:

Year:  2004        PMID: 15340259     DOI: 10.1023/B:FAME.0000039849.86008.b7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  53 in total

1.  Immunohistochemical evaluation of global DNA methylation: comparison with in vitro radiolabeled methyl incorporation assay.

Authors:  C J Piyathilake; G L Johanning; A R Frost; M A Whiteside; U Manne; W E Grizzle; D C Heimburger; A Niveleau
Journal:  Biotech Histochem       Date:  2000-11       Impact factor: 1.718

2.  Late onset and high incidence of colon cancer of the mutator phenotype with hypermethylated hMLH1 gene in women.

Authors:  S R Malkhosyan; H Yamamoto; Z Piao; M Perucho
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

3.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome.

Authors:  P Jeevaratnam; D S Cottier; P J Browett; N S Van De Water; V Pokos; J R Jass
Journal:  J Pathol       Date:  1996-05       Impact factor: 7.996

5.  Methylation of the hMLH1 and hMSH2 promoter in early-onset sporadic colorectal carcinomas with microsatellite instability.

Authors:  Hee C Kim; Chang N Kim; Chang S Yu; Seon A Roh; Jin C Kim
Journal:  Int J Colorectal Dis       Date:  2002-11-30       Impact factor: 2.571

6.  Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age.

Authors:  Sanjay Kakar; Lawrence J Burgart; Stephen N Thibodeau; Kari G Rabe; Gloria M Petersen; Richard M Goldberg; Noralane M Lindor
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

7.  Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum.

Authors:  A E Biemer-Hüttmann; M D Walsh; M A McGuckin; Y Ajioka; H Watanabe; B A Leggett; J R Jass
Journal:  J Histochem Cytochem       Date:  1999-08       Impact factor: 2.479

8.  Concordant CpG island methylation in hyperplastic polyposis.

Authors:  Annie On-On Chan; Jean-Pierre J Issa; Jeffrey S Morris; Stanley R Hamilton; Asif Rashid
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

9.  Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.

Authors:  Marsha L Frazier; Lixuan Xi; Jihong Zong; Nancy Viscofsky; Asif Rashid; Elsie F Wu; Patrick M Lynch; Christopher I Amos; Jean-Pierre J Issa
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

Review 10.  Emerging concepts in colorectal neoplasia.

Authors:  Jeremy R Jass; Vicki L J Whitehall; Joanne Young; Barbara A Leggett
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

View more
  52 in total

1.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.

Authors:  Miguel Serrano; Pedro Lage; Sara Belga; Bruno Filipe; Inês Francisco; Paula Rodrigues; Ricardo Fonseca; Paula Chaves; Isabel Claro; Cristina Albuquerque; António Dias Pereira
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

3.  BRAF mutation and gene methylation frequencies of colorectal tumours with microsatellite instability increase markedly with patient age.

Authors:  B Iacopetta; W Q Li; F Grieu; A Ruszkiewicz; K Kawakami
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

4.  Detection of germline mutations of hMLH1 and hMSH2 based on cDNA sequencing in China.

Authors:  Chao-Fu Wang; Xiao-Yan Zhou; Tai-Ming Zhang; Meng-Hong Sun; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

5.  A case of more abundant and dysplastic adenomas in the interposed colon than in the native colon.

Authors:  Hye Jin Hwang; Kyung Ho Song; Young Hoon Youn; Ji Eun Kwon; Hoguen Kim; Jae Bock Chung; Yong Chan Lee
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

6.  Immunology and the Lynch syndrome.

Authors:  Henry T Lynch; Kristen M Drescher; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2008-04       Impact factor: 22.682

7.  Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.

Authors:  Hanifa Bouzourene; Pierre Hutter; Lorena Losi; Patricia Martin; Jean Benhattar
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

8.  Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.

Authors:  Jenny N Poynter; Kimberly D Siegmund; Daniel J Weisenberger; Tiffany I Long; Stephen N Thibodeau; Noralane Lindor; Joanne Young; Mark A Jenkins; John L Hopper; John A Baron; Dan Buchanan; Graham Casey; A Joan Levine; Loïc Le Marchand; Steven Gallinger; Bharati Bapat; John D Potter; Polly A Newcomb; Robert W Haile; Peter W Laird
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  Tumor histology helps to identify Lynch syndrome among colorectal cancer patients.

Authors:  Brindusa Truta; Yunn-Yi Chen; Amie M Blanco; Guoren Deng; Peggy G Conrad; Yong Ho Kim; Eun Taek Park; Sanjay Kakar; Young S Kim; Fernando Velayos; Marvin H Sleisenger; Jonathan P Terdiman
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

10.  Fas ligand expression in lynch syndrome-associated colorectal tumours.

Authors:  Jan J Koornstra; Steven de Jong; Wietske Boersma-van Eck; Nynke Zwart; Harry Hollema; Elisabeth G E de Vries; Jan H Kleibeuker
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.